ArticleJournal of managed care & specialty pharmacy2025

Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease.

Jaehong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.